Study Summary
This trial will test whether a digital neurotherapy can help relieve depression, improve cognition, and quality of life in cancer survivors.
Eligible Conditions
- Depression
- Quality of Life
- Cognition
Treatment Effectiveness
Effectiveness Progress
Study Objectives
11 Primary · 0 Secondary · Reporting Duration: Baseline, 4 weeks, 8 weeks
Week 8
Change in California Verbal Learning Test-II
Change in Controlled Oral Word Association Test
Change in Flanker Task
Change in Functional Assessment of Cancer Therapy-General
Change in Hospital Anxiety and Depression Questionnaire
Change in List Sort Working Memory
Change in Logical Memory
Change in Mindful Attention Awareness Scale
Change in Multidimensional Executive Function Screening Test
Change in Patient Health Questionnaire-9
Change in Short-Form 36 Health Survey
Trial Safety
Safety Progress
Trial Design
2 Treatment Groups
Wait list control group
1 of 2
Digital neurotherapy (DNT) Treatment
1 of 2
Active Control
Experimental Treatment
50 Total Participants · 2 Treatment Groups
Primary Treatment: Digital neurotherapy (DNT) Treatment · No Placebo Group · N/A
Digital neurotherapy (DNT) Treatment
Behavioral
Experimental Group · 1 Intervention: Digital neurotherapy (DNT) Treatment · Intervention Types: BehavioralWait list control group
Behavioral
ActiveComparator Group · 1 Intervention: Wait list control group · Intervention Types: BehavioralTrial Logistics
Trial Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: baseline, 4 weeks, 8 weeks
Who is running the clinical trial?
Yale UniversityLead Sponsor
1,680 Previous Clinical Trials
21,088,209 Total Patients Enrolled
52 Trials studying Depression
8,444 Patients Enrolled for Depression
Jennifer Kilkus, MDPrincipal InvestigatorYale University
Eligibility Criteria
Age 18+ · All Participants · 6 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:You are willing to comply with all study procedures and are available for the duration of the study.
You have received chemotherapy, and/or radiation treatment, and/or immunotherapy treatment for cancer.
You are able to understand and read English.
Who else is applying?
What state do they live in?
| Connecticut | 100.0% |
How old are they?
| 18 - 65 | 100.0% |
What site did they apply to?
| Yale New Haven Hospital | 100.0% |
What portion of applicants met pre-screening criteria?
| Met criteria | 100.0% |
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Conditions
Cancer Related
Treatments